Class actions were commenced in British Columbia, Alberta, Ontario and Quebec against Loblaw Companies Limited (" Loblaw "), Shoppers Drug Mart Inc. (" SDM ") and Sanis Health Inc. (" Sanis "), in relation to the manufacture, distribution and sale of opioid drugs in Canada from 1996, when Purdue Pharma began to sell OxyContin.